• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Merck (DE) (Group)

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 51,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene- editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – Merck is everywhere. In 2017, Merck generated sales of €15.3 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the business sectors operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. *

 

	Start	1668-01-01 established_pre
	Industry	pharmaceutical
	Industry 2	reagents (bio/biochemical)
	Person	Oschmann, Stefan (Merck (DE) 201604– CEO before Executive Board Member since 2011 before MSD)
	Person 2	Kuhnert, Marcus (Merck (DE) 201408– CFO before CFO of Henkel Laundry + Home Care businss unit)
	Region	Darmstadt
	Country	Germany
	Street	250 Frankfurter Str.
	City	64293 Darmstadt
	Tel	+49-6151-72-0
		Address record changed: 2019-03-08
Basic data	Employees	I: 50,001 to 100,0 (2018-12-31)
	Currency	EUR
	Annual sales	14,836,000,000 (sales, net, consolidated (2018) 2018-12-31)
	Profit	3,396,000,000 (2018-12-31)
	Cash	2,170,000,000 (2018-12-31)
		* Document for �About Section�: Merck KGaA. (3/4/19). "Press Release: Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology". Darmstadt.
		Record changed: 2019-08-07

Advertisement

More documents for Merck (DE) (Group)

• [1] GlaxoSmithKline plc. (8/12/19). "Press Release: GSK Announces Leadership Changes in the US". Philadeliphia, PA....
• [2] Merck KGaA. (8/6/19). "Press Release: Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab". Darmstadt....
• [3] Yumab GmbH. (7/22/19). "Press Release: Yumab Announces New Research and Collaboration Agreement with Merck". Braunschweig....
• [4] Merck KGaA. (7/18/19). "Press Release: Intermolecular Stockholders Approve Acquisition by Merck". Darmstadt....
• [5] Merck KGaA. (7/18/19). "Press Release: Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation". Darmstadt....
• [6] Start Codon Ltd.. (7/10/19). "Press Release: Start Codon Strengthens Senior Team with Key Appointments". Cambridge....
• [7] Merck KGaA. (7/1/19). "Press Release: Merck Places Bonds Amounting to € 2 Billion. Issuance Is Final Key Component in the Financing of the Planned Versum Transaction". Darmstadt....
• [8] Merck KGaA. (6/18/19). "Press Release: Merck Places Hybrid Bond Amounting to € 1.5 Billion. Placement Is an Important Part of the Financing of the Planned Acquisition of Versum Materials, Inc.". Darmstadt....
• [9] Merck KGaA. (6/6/19). "Press Release: Merck and Rigaku Form Partnership to Develop Novel Molecular Structure Analysis Technology". Darmstadt....
• [10] DNA Script. (5/16/19). "Press Release: DNA Script Raises $38.5 Million in Series B Financing. Oversubscribed Round Led by LSP". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.